Maze Therapeutics Cash Flow Statement (2024-2026) | MAZE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -27.73M139.06M-24.73M-29.65M-32.79M-33.68M-30.09M-34.57M-24.21M
Depreciation and Depletion (Quarter) 0.95M0.85M0.79M0.71M0.68M0.65M0.57M0.50M0.44M
Share-based Compensation (Quarter) 2.31M2.14M2.34M2.85M3.23M3.24M3.86M6.07M7.11M
Gains from Sales and Divestitures (Quarter) 0.03M1.11M
Gains from Investment Securities (Quarter) 5.28M5.35M5.75M0.31M6.07M
Non-cash Items (Quarter) 30.00M1.30M1.60M13.90M2.72M58.00M
Cash from Operations (Quarter) -23.44M145.05M-23.20M-22.45M-29.52M-30.05M-24.64M-27.73M-39.11M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.23M0.00M
Amortization of Deferred Charges (Quarter) 0.37M
Depreciation & Amortization (CF) (Quarter) 0.95M0.85M0.79M0.71M0.68M0.65M0.57M0.50M0.44M
Change in Working Capital
Change in Receivables (Quarter) 20.00M
Change in Account Payables (Quarter) -0.24M0.39M-1.17M0.82M0.58M1.27M-0.75M-1.12M2.21M
Change in Accured Expenses (Quarter) -0.13M3.80M-1.70M1.84M-1.06M0.11M2.48M1.96M-4.07M
Investing Activities
Capital Expenditures (Quarter) 0.05M0.39M0.10M0.60M0.30M0.39M0.07M-0.76M0.01M
Change in Acquisitions & Divestments (Quarter) 30.00M
Cash from Investing Activities (Quarter) -0.28M-0.16M-0.10M-0.60M-0.30M-0.39M-66.88M-103.39M6.28M
Financing Activities
Other financing activities (Quarter) 15.40M0.89M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 39.40M
Change in Capital Stock
Shares Issued (Quarter) 0.36M0.08M0.23M0.06M0.13M141.62M-0.48M4.08M
Misc.
Cash from Financing Activities (Quarter) 24.58M0.15M-2.15M70.26M127.38M0.61M143.76M3.59M42.36M
Change in Cash (Quarter) 0.86M145.04M-25.46M47.20M97.56M-29.83M52.23M-127.53M9.52M
Free Cash Flow (Quarter) -23.48M144.66M-23.31M-23.06M-29.82M-30.45M-24.71M-26.98M-39.12M
Net Cash Flow (Quarter) 0.86M145.04M-25.46M47.20M97.56M-29.83M52.23M-127.53M9.52M